Deep learning and neural networks stands as a subset of machine learning, drawing inspiration from the structural complexities of the human brain. Its essence lies in neural networks comprising interconnected nodes organized in layers, facilitating the extraction of nuanced patterns from vast datasets. Through iterative training processes, these networks learn to make predictions, refining internal parameters based on input-output examples. Deep learning's impact spans diverse domains such as computer vision, natural language processing, and speech recognition, catalyzing transformative breakthroughs. Convolutional neural networks excel in tasks like image classification and object detection, while recurrent neural networks demonstrate prowess in sequence modeling, including language translation and time series prediction. Fueled by advancements in computational hardware and the availability of massive datasets, the adoption of deep learning has surged. Open-source frameworks like TensorFlow and PyTorch have democratized its application, empowering researchers and practitioners alike. However, challenges persist, encompassing the voracious appetite for labeled data and the interpretability quandary posed by intricate models. Ethical considerations loom large, touching upon issues of fairness, bias mitigation, and security. Nonetheless, ongoing research endeavors endeavor to surmount these obstacles, augmenting deep learning's capabilities. As the field advances, deep learning stands poised to reshape the landscape of artificial intelligence, propelling innovation across sectors and pushing the boundaries of human understanding and ingenuity.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States